References
- Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342. https://doi.org/10.1038/nature05354
- Chang HC, Yang HC, Chang HY, Yeh CJ, Chen HH, Huang KC, Pan WH (2017) Morbid obesity in Taiwan: Prevalence, trends, associated social demographics, and lifestyle factors. PLOS ONE 12:e0169577. https://doi.org/10.1371/journal.pone.0169577
- Chen PH, Chen GC, Yang MF, Hsieh CH, Chuang SH, Yang HL, Kuo YH, Chyuan JH, Chao PM (2012) Bitter melon seed oil-attenuated body fat accumulation in diet-induced obese mice is associated with cAMPdependent protein kinase activation and cell death in white adipose tissue. J Nutr 142:1197-1204. https://doi.org/10.3945/jn.112.159939
- Chen Q, Li ET (2005) Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines. Br J Nutr 93:747-754. https://doi.org/10.1079/BJN20051388
- Fuangchan A, Sonthisombat P, Seubnukarn T, Chanouan R, Chotchaisuwat P, Sirigulsatien V, Ingkaninan K, Plianbangchang P, Haines ST (2011) Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J Ethnopharmacol 134:422-428. https://doi.org/10.1016/j.jep.2010.12.045
- Graf BL, Raskin I, Cefalu WT, Ribnicky DM (2010) Plantderived therapeutics for the treatment of metabolic syndrome. Curr Opin Investig Drugs 11:1107-1115.
- Hafizur RM, Kabir N, Chishti S (2011) Modulation of pancreatic beta-cells in neonatallystreptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp. Nat Prod Res 25:353-367. https://doi.org/10.1080/14786411003766904
- Han CY, Ki SH, Kim YW, Noh K, Lee DY, Kang B, Ryu JH, Jeon R, Kim EH, Hwang SJ, Kim SG (2011) Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation. Antioxid Redox Signal 14:187-202. https://doi.org/10.1089/ars.2010.3190
- Han TS, Lean ME (2016) A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis 5:2048004016633371.
- Hardie DG (2008) AMPK: A key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 32:S7-S12. https://doi.org/10.1038/ijo.2008.116
- Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M (2013) A systematic review of anti-obesity medicinal plants: An update. J Diabetes Metab Disord 12:28. https://doi.org/10.1186/2251-6581-12-28
- Jung UJ, Choi MS (2014) Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15:6184-6223. https://doi.org/10.3390/ijms15046184
- Keller KB, Lemberg L (2003) Obesity and the metabolic syndrome. Am J Crit Care 12:167-170. https://doi.org/10.4037/ajcc2003.12.2.167
- Kim GS, Park HJ, Woo JH, Kim MK, Koh PO, Min W, Ko YG, Kim CH, Won CK, Cho JH (2012) Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells. BMC Complement Altern Med 12:31.
- Kopelman PG (2000) Obesity as a medical problem. Nature 404:635-643. https://doi.org/10.1038/35007508
- Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122. https://doi.org/10.1016/j.cell.2006.11.013
- Mayoral R, Osborn O, McNelis J, Johnson AM, Oh DY, Izquierdo CL, Chung H, Li P, Traves PG, Bandyopadhyay G, Pessentheiner AR, Ofrecio JM, Cook JR, Qiang L, Accili D, Olefsky JM (2015) Adipocyte SIRT1 knockout promotes PPARgamma activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity. Mol Metab 4:378-391. https://doi.org/10.1016/j.molmet.2015.02.007
- Moon JH, Choi DW, Kim SE, Seomoon JH, Hong SY, Kim HK, Cho KM, Song J, Kang SS, Kim KH, Kwon OK (2015) Comparison of biological activities of ethanol extracts of unripe fruit of bitter melon (Momordica charantia L.) cultivated in Hamyang, Korea. J Korean Soc Food Sci Nutr 44:1637-1644. https://doi.org/10.3746/jkfn.2015.44.11.1637
-
Mouchiroud L, Houtkooper RH, Auwerx J (2013)
$NAD(^{+})$ metabolism: A therapeutic target for age-related metabolic disease. Crit Rev Biochem Mol Biol 48:397-408. https://doi.org/10.3109/10409238.2013.789479 - Park HJ, Chung BY, Lee MK, Song Y, Lee SS, Chu GM, Kang SN, Song YM, Kim GS, Cho JH (2012) Centipede grass exerts anti-adipogenic activity through inhibition of C/EBPbeta, C/EBPalpha, and PPARgamma expression and the AKT signaling pathway in 3T3-L1 adipocytes. BMC Complement Altern Med 12:230. https://doi.org/10.1186/1472-6882-12-S1-P230
- Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH (2008) Sirt1 protects against high-fat dietinduced metabolic damage. Proc Natl Acad Sci USA 105:9793-9798. https://doi.org/10.1073/pnas.0802917105
- Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429:771-776. https://doi.org/10.1038/nature02583
- Pi-Sunyer X (2009) The medical risks of obesity. Postgrad Med 121:21-33. https://doi.org/10.3810/pgm.2009.11.2074
- Ray RB, Raychoudhuri A, Steele R, Nerurkar P (2010) Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res 70:1925-1931. https://doi.org/10.1158/0008-5472.CAN-09-3438
- Ru P, Steele R, Nerurkar PV, Phillips N, Ray RB (2011) Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model. Cancer Prev Res (Phila) 4:2122-2130. https://doi.org/10.1158/1940-6207.CAPR-11-0376
- Shih CC, Lin CH, Lin WL (2008) Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet. Diabetes Res Clin Pract 81:134-143. https://doi.org/10.1016/j.diabres.2008.04.023
- Srivastava RA, Pinkosky SL, Filippov S, Hanselman JC, Cramer CT, Newton RS (2012) AMP-activated protein kinase: An emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardiometabolic diseases. J Lipid Res 53:2490-2514. https://doi.org/10.1194/jlr.R025882
- Vingtdeux V, Chandakkar P, Zhao H, Davies P, Marambaud P (2011) Small-molecule activators of AMPactivated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis. Mol Med 17:1022-1030. https://doi.org/10.2119/molmed.2011.00163
- Yang JW, Kim SS (2015) GinsenosideRc promotes antiadipogenic activity on 3T3-L1 adipocytes by downregulating C/EBP alpha and PPARgamma. Molecules 20:1293-1303. https://doi.org/10.3390/molecules20011293
- Ye X, Li M, Hou T, Gao T, Zhu WG, Yang Y (2017) Sirtuins in glucose and lipid metabolism. Oncotarget 8:1845-1859. https://doi.org/10.18632/oncotarget.12157
- Yoon NA, Park J, Lee J, Jeong JY, Kim HK, Lee HS, Hwang IG, Roh GS, Kim HJ, Cho GJ, Choi WS, Lee DH, Kang SS (2017) Anti-diabetic effects of ethanol extract from bitter melon in mice fed a high-fat diet. Dev Reprod 21:259-267. https://doi.org/10.12717/DR.2017.21.3.259